294 related articles for article (PubMed ID: 11106083)
21. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
[TBL] [Abstract][Full Text] [Related]
22. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma.
Kadin ME; Drews R; Samel A; Gilchrist A; Kocher O
Hum Pathol; 2001 Nov; 32(11):1269-72. PubMed ID: 11727269
[TBL] [Abstract][Full Text] [Related]
24. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
[TBL] [Abstract][Full Text] [Related]
25. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma.
Konstantinou K; Yamamoto K; Ishibashi F; Mizoguchi Y; Kurata M; Nakagawa Y; Suzuki K; Sawabe M; Ohta M; Miyakoshi S; Crawley JT; Kitagawa M
Br J Haematol; 2009 Mar; 144(5):696-704. PubMed ID: 19120365
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
28. Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases.
Servitje O; Martí RM; Estrach T; Palou J; Gallardo F; Limón A; Romagosa V
Eur J Dermatol; 2000; 10(1):43-6. PubMed ID: 10694298
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated proliferative disorder presenting as Hodgkin's lymphoma and developing as aggressive natural killer-cell leukemia 19 years later: a case report of composite lymphoma.
Oka K; Nagayama R; Mori N
Pathol Res Pract; 2009; 205(10):730-4. PubMed ID: 19269751
[TBL] [Abstract][Full Text] [Related]
30. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
31. In situ follicular lymphoma associated with overt B- or T-cell lymphomas in the same lymph node.
Carbone A; Della Libera D; Zannier L; Selva A; Ceolin P; Gualeni A; Canal B; Gloghini A
Am J Hematol; 2011 Dec; 86(12):E66-70. PubMed ID: 21956856
[TBL] [Abstract][Full Text] [Related]
32. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
33. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
34. Extranodal CD20-positive peripheral T-cell lymphoma presenting with adrenal and testicular masses.
Makita M; Murakami I; Yoshioka T; Tanaka H; Yamamoto K; Imajo K; Takata K; Yoshino T
Rinsho Ketsueki; 2009 May; 50(5):413-8. PubMed ID: 19483402
[TBL] [Abstract][Full Text] [Related]
35. T-cell lymphoma developing in Hodgkin's disease: evidence for two clones.
Wlodarska I; Delabie J; De Wolf-Peeters C; Mecucci C; Stul M; Verhoef G; Cassiman JJ; Van den Berghe H
J Pathol; 1993 Jul; 170(3):239-48. PubMed ID: 8133397
[TBL] [Abstract][Full Text] [Related]
36. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
Kalyan K; Basu D; Soundararaghavan J
Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
Li T; Zhang B; Ye Y; Yin H
Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
[TBL] [Abstract][Full Text] [Related]
39. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
40. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.
Chu PG; Loera S; Huang Q; Weiss LM
Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
